Will the Long-Named Perfluorohexyloctane Produce Long-lasting Improvements in Patients With Meibomian Gland Disease?

JAMA Ophthalmol. 2023 Apr 1;141(4):392-393. doi: 10.1001/jamaophthalmol.2023.0399.
No abstract available

Publication types

  • Comment

MeSH terms

  • Dry Eye Syndromes*
  • Eyelid Diseases*
  • Fluorocarbons*
  • Humans
  • Meibomian Glands
  • Tears

Substances

  • perfluorohexyl-octan
  • Fluorocarbons